Fermenta Biotech standalone net profit declines 21.58% in the June 2021 quarter

Image
Capital Market
Last Updated : Aug 13 2021 | 3:50 PM IST

Sales rise 7.88% to Rs 108.88 crore

Net profit of Fermenta Biotech declined 21.58% to Rs 12.79 crore in the quarter ended June 2021 as against Rs 16.31 crore during the previous quarter ended June 2020. Sales rose 7.88% to Rs 108.88 crore in the quarter ended June 2021 as against Rs 100.93 crore during the previous quarter ended June 2020. ParticularsQuarter EndedJun. 2021Jun. 2020% Var.Sales108.88100.93 8 OPM %25.3324.63 -PBDT24.4722.52 9 PBT19.0118.64 2 NP12.7916.31 -22

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 13 2021 | 3:23 PM IST

Next Story